gbo Medizintechnik AG

gbo Medizintechnik AG specializes in transcutaneous neuromuscular electrical stimulation (TENS) systems tailored for physical therapy. These devices, such as the HiTop 4touch, HiTop 1touch, and HiTop 2touch, are designed to deliver controlled electrical stimulation for muscle activation, pain relief, and rehabilitation purposes. The focus is on portable, user-friendly systems for clinical and home use.

gbo Medizintechnik AG is based in the United States. This location means its devices are subject to U.S. regulatory requirements, including classification under the FDA’s medical device regulations. The company’s products are listed in the FDA’s Unique Device Identifier (UDI) database, which helps ensure traceability and compliance with U.S. medical device laws.

The devices produced by gbo Medizintechnik AG are classified as Class II medical devices. This classification is determined by factors like the intended use (e.g., physical therapy) and the level of risk associated with the device. Class II devices typically require special controls beyond general controls to ensure safety and effectiveness, such as performance standards or post-market surveillance.

The devices manufactured by gbo Medizintechnik AG are included in the FDA’s Unique Device Identifier (UDI) database. The UDI system assigns a unique product identifier to each device, enabling better tracking, transparency, and compliance monitoring in the U.S. market. This listing helps healthcare providers, regulators, and patients verify the identity and regulatory status of the company’s products.